Broadfin Healthcare Master Fund Ltd Insider Trading $AEGR Aegerion Pharmaceuticals, Inc.
Get free email notifications about insider trading for Broadfin Healthcare Master Fund Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Broadfin Healthcare Master Fund Ltd. Broadfin Healthcare Master Fund Ltd is 10% Owner in NOVELION THERAPEUTICS INC. ($QLTI) and Director in NOVELION THERAPEUTICS INC. ($NVLN) and 10% Owner in PROGENICS PHARMACEUTICALS INC ($PGNX) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($FLML) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and 10% Owner in STRATA Skin Sciences, Inc. ($MELA) and 10% Owner in Aegerion Pharmaceuticals, Inc. ($AEGR) and 10% Owner in ARATANA THERAPEUTICS, INC. ($PETX) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Recro Pharma, Inc. ($REPH).
Broadfin Healthcare Master Fund Ltd in Aegerion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Broadfin Healthcare Master Fund Ltd: 10% Owner
Holdings: 0 shares
Latest Transaction: Dec 01 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Broadfin Healthcare Master Fund Ltd in Aegerion Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, PETX, AVDL, BDSI, CORI, MYG, NVLN, PGNX, REPH, MELA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 01 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 0.00 | 4,361,291 | 0 | 0 | 4.4 M to 0 (-100.00 %) |
| Sep 14 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.75 | 75,000 | 131,250 | 4,361,291 | 4.3 M to 4.4 M (+1.75 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 76,000 | 129,200 | 4,286,291 | 4.2 M to 4.3 M (+1.81 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 100,000 | 169,600 | 4,210,291 | 4.1 M to 4.2 M (+2.43 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.60 | 100,000 | 159,500 | 4,110,291 | 4 M to 4.1 M (+2.49 %) |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 4,976 | 37,320 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | E | 17.50 | 5,000 | 87,500 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 24 | 180 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 497,600 | 3,732,000 | 4,010,291 | 3.5 M to 4 M (+14.17 %) |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 2,400 | 18,000 | 3,512,691 | 3.5 M to 3.5 M (+0.07 %) |
| Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.96 | 35,000 | 383,600 | 4,010,291 | 4 M to 4 M (+0.88 %) |
| Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.99 | 5,100 | 56,049 | 3,975,291 | 4 M to 4 M (+0.13 %) |
Page: 1